not everyone that is frustrated or states a negative opinion even while holding this stock is short...i am now at break even after holding what appears as to long as well...i love the technology and want it to work but as a financial investment it might be time to move to better opportunities for me..so i will be looking for a good exit...hog
How are the insider trading numbers anything but negative? They do nothing but sell their shares. If they were aware of impending big contracts I suspect we would see a different trend. Why do you want retail investors to buy from insiders who don't seem to have much faith in their own company?
The institutional holdings numbers are better than I thought but still bad. Most shareholders are retail investors who think the idea is cool and who think they found a goldmine but don't realize that they seem to be donating to a research institution rather than investing in a company who plans to return value to shareholders anytime soon.
In the meantime please let me know if there is reason to believe that any pharmaceutical company is interested in these liver tissues because I have seen no evidence whatsoever.
This company should not be traded on the Nasdaq it doesn't seem to be anything but a research organization all I see is pr's about presentations and collaboration with academia.
Market Data 
Markets 
AI
